Intracavitary mitomycin-C in the treatment of superficial urothelial tumors: a preliminary report.
Nine patients with a variety of surface transitional cell neoplastic lesions received topical mitomycin-C. The results of treatment were encouraging, all patients responding completely or partially. Based on this experience the authors are participating in a study to compare the efficacy of mitomycin-C with that of thio-tepa.
D000287:Administration, Topical; D000368:Aged; D002278:Carcinoma in Situ / Q000188:drug therapy; D006801:Humans; D008297:Male; D008875:Middle Aged; D008937:Mitomycins / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D010212:Papilloma / Q000188:drug therapy; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy*
D008937:Mitomycins